OCUGENIX
Ocugenix is a therapeutics company focused on the development of cancer immunotherapy drugs intended to treat eye diseases. Its cancer immunotherapy drug is a medicine against drug-resistant bacteria, enabling doctors to perform a cancer-related eye treatment.
OCUGENIX
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2015-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.ocugenix.com
Total Employee:
1+
Status:
Active
Contact:
412-600-6379
Email Addresses:
[email protected]
Total Funding:
150 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Sitelinks Search Box
Current Employees Featured
Sean McDonald
Sean McDonald President & CEO @ Ocugenix President & CEO
Investors List
Innovation Works
Innovation Works investment in Seed Round - Ocugenix
Innovation Works
Innovation Works investment in Seed Round - Ocugenix
Innovation Works
Innovation Works investment in Convertible Note - Ocugenix
Official Site Inspections
http://www.ocugenix.com
- Host name: box5675.bluehost.com
- IP address: 162.241.252.14
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
Loading ...